Ind-Swift Laboratories is trading at INR 224.49, down 5% today, as the stock gives back a portion of its recent gains in a move likely driven by profit-taking.

  • No fresh company-specific news, earnings releases, or regulatory actions have been identified for July 28–29, 2026, to explain the pullback.
  • The price action appears to be a result of normal volatility following a sharp multi-month rally.
  • The decline moves against the generally positive performance seen across the broader healthcare sector.